Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP542428.RAQjNQl8M6QMVwfrAB_d4SGymlcxwCZm_xgHTL1nAnolg130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542428.RAQjNQl8M6QMVwfrAB_d4SGymlcxwCZm_xgHTL1nAnolg130_provenance.
• NP853245.RAe4dqSGKvJQejKp1-w-3Ac2JAlSYEFC8Q-rbNadnoCNE130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853245.RAe4dqSGKvJQejKp1-w-3Ac2JAlSYEFC8Q-rbNadnoCNE130_provenance.
• NP892758.RAojhx7nBeSHwyc_4Y3wGMCkWaH3nZ4oduMFcU44HkyL8130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892758.RAojhx7nBeSHwyc_4Y3wGMCkWaH3nZ4oduMFcU44HkyL8130_provenance.
• NP373731.RA7nsGsETnvVyvj5gIUvxrfFQ-hAIq4X8YQRgkh_V4Zlw130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373731.RA7nsGsETnvVyvj5gIUvxrfFQ-hAIq4X8YQRgkh_V4Zlw130_provenance.
• NP198300.RAsqjGeBJQWJ1j5NFLnWTRJ_kZkhQIXtoF8xxR0S1ReSI130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198300.RAsqjGeBJQWJ1j5NFLnWTRJ_kZkhQIXtoF8xxR0S1ReSI130_provenance.
• NP435934.RAi5C7iSbz2uD3JPe5R8E1LGwdcGhCMkfgEM7jCyXGiTo130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435934.RAi5C7iSbz2uD3JPe5R8E1LGwdcGhCMkfgEM7jCyXGiTo130_provenance.
• NP857864.RAVJBELPUwiGLBz0FhMvfUtikgf0lRAz_cKnqN79fuIS8130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857864.RAVJBELPUwiGLBz0FhMvfUtikgf0lRAz_cKnqN79fuIS8130_provenance.
• NP769662.RAVkHq3dUPXyTE2rk0zA9lYCmpuUrJR5nbUT33HcvgI8Q130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769662.RAVkHq3dUPXyTE2rk0zA9lYCmpuUrJR5nbUT33HcvgI8Q130_provenance.
• NP974409.RAgmNMQmsZzM-t0-p8TIK8C7j5D0Mp_egyRDE2B89UBok130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974409.RAgmNMQmsZzM-t0-p8TIK8C7j5D0Mp_egyRDE2B89UBok130_provenance.
• NP769663.RAonU9e-O9qCPhewmjq5N7I_mCMNlnLtDLXj5-rzbRlwc130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769663.RAonU9e-O9qCPhewmjq5N7I_mCMNlnLtDLXj5-rzbRlwc130_provenance.
• NP769665.RAu_VbfLPMrvbDz1ssXJbzhKuJDbDlTzdxCWmxn_g7g7U130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769665.RAu_VbfLPMrvbDz1ssXJbzhKuJDbDlTzdxCWmxn_g7g7U130_provenance.
• NP769667.RApMMg251CtaRUkcXj209gL23LbXp9cnIskp82BBuF_Cw130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769667.RApMMg251CtaRUkcXj209gL23LbXp9cnIskp82BBuF_Cw130_provenance.
• NP372579.RA81pJSoX54op7VeMMcKrx1bAW5ag_8FhJL0emrUI0Jgc130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372579.RA81pJSoX54op7VeMMcKrx1bAW5ag_8FhJL0emrUI0Jgc130_provenance.
• NP217403.RAKAqN1f_XAZF7eGtuUqOko9rkmIDpvhMSm7G58Xu6lyg130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217403.RAKAqN1f_XAZF7eGtuUqOko9rkmIDpvhMSm7G58Xu6lyg130_provenance.
• NP769664.RAG113oROisi2YPBBD2iJcITVHKOoVThRlbruNdKoaYYM130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769664.RAG113oROisi2YPBBD2iJcITVHKOoVThRlbruNdKoaYYM130_provenance.
• NP769666.RAEgWPVVKQ3uf6nDNpcXtgkPrnrBMTzkHcRV9KRrhia9c130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769666.RAEgWPVVKQ3uf6nDNpcXtgkPrnrBMTzkHcRV9KRrhia9c130_provenance.
• NP769669.RAGCZtl_mKdcZEMFZPQxuS7PQ69DKC_gpVnQMYO9M1jWo130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769669.RAGCZtl_mKdcZEMFZPQxuS7PQ69DKC_gpVnQMYO9M1jWo130_provenance.
• NP698179.RA7ylD1FmxmihnvRWPD8IwiQYybtEwPSvI3Mac6sUARYA130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698179.RA7ylD1FmxmihnvRWPD8IwiQYybtEwPSvI3Mac6sUARYA130_provenance.
• NP769668.RAzRJ8JPSuEF1YKjvxvJWtcMR-HvMzGM2EBCnOgBnHSGc130_assertion description "[These findings suggest that slow metabolic phenotype of NAT2 maybe one of risk factor for TCE-induced hypersensitivity dermatitis and combined slow acetylator phenotypes of NAT1 and NAT2 further increase such risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769668.RAzRJ8JPSuEF1YKjvxvJWtcMR-HvMzGM2EBCnOgBnHSGc130_provenance.